N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

Term ID

CHEBI:150802

Synonyms

Definition

References

glygen:G43212ES
glytoucan:G43212ES

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

Phenotype where environments contain N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

Phenotype modified by environments containing N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

Phenotype affecting N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

Human Disease Model